공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 소화 효소 시장(2020-2027년)

Global Digestive Enzymes Market - 2021-2028

리서치사 DataM Intelligence
발행일 On Demand Report 상품 코드 965963
페이지 정보 영문 180 Pages
가격
US $ 4,350 ₩ 5,176,000 PDF & Excel (Single User License)
US $ 4,850 ₩ 5,771,000 PDF & Excel (Multiple User License)
US $ 7,850 ₩ 9,340,000 PDF & Excel (Enterprise License)


세계의 소화 효소 시장(2020-2027년) Global Digestive Enzymes Market - 2021-2028
발행일 : On Demand Report 페이지 정보 : 영문 180 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 소화 효소 시장은 위장장애 환자 증가, 위장 건강에 관한 지식 보급, 예방적 건강 관리에 대한 관심 증대, 고령자 인구 증가 등의 요인에 지지되어 향후에도 확대 경향이 계속될 것으로 보입니다. 신종 코로나바이러스 감염증(COVID-19) 감염 확대 시기에도 소화 촉진에 의한 면역 기능 강화를 노려 소화 효소가 처방되는 경우가 많아, 그것도 시장 성장 촉진에 기여하고 있습니다.

세계의 소화 효소(Digestive Enzymes) 시장에 대해 분석했으며, 시장의 기본 구조 및 최신 상황, 전체적인 시장 동향 전망(향후 8년간), 효소 종류별·원료별·용도별·유통 채널별 및 지역별 상세 동향, 주요 시장 성장 촉진·억제요인, 시장 경쟁 구조, 주요 기업 개요·사업 전략, 신종 코로나바이러스 감염증(COVID-19)의 영향 등에 대해 조사했습니다.

목차

제1장 세계의 소화 효소 시장 : 분석 방법과 범위

제2장 세계의 소화 효소 시장 : 시장 정의와 개요

제3장 세계의 소화 효소 시장 : 주요 요약

제4장 세계의 소화 효소 시장 : 시장 역학

  • 시장에 대한 영향요인
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 영향력 분석

제5장 세계의 소화 효소 시장 : 업계 분석

  • Porter's Five Forces 분석
  • 공급망 분석
  • 가격 분석
  • 규제 분석
  • 상환 분석
  • 미충족 수요

제6장 세계의 소화 효소 시장 : 신종 코로나바이러스 감염증(COVID-19) 분석

  • Covid-19의 시장에 대한 영향 분석
    • Before COVID-19/과거 시장 시나리오
    • Present COVID-19/현재 시장 시나리오
    • After COVID-19/향후 시장 시나리오
  • Covid-19 유행중 가격 동향
  • 수요·공급 변동역
  • 감염 확대시 시장에 관한 정부의 대처
  • 제조업체의 전략적 이니셔티브
  • 결론

제7장 세계의 소화 효소 시장 : 효소 종류별

  • 서론
  • 시장 규모 분석과 전년대비 성장률(YoY) : 효소 종류별
  • 시장 매력 지수 : 효소 종류별
    • 카르보히드라아제
    • 프로테아제
    • 리파아제
    • 아밀라아제
    • 말타아제
    • 락타아제
    • 기타

제8장 세계의 소화 효소 시장 : 원료별

  • 서론
  • 시장 규모 분석과 전년대비 성장률(YoY) : 원료별
  • 시장 매력 지수 : 원료별
    • 동물
    • 미생물
    • 식물

제9장 세계의 소화 효소 시장 : 용도별

  • 서론
  • 시장 규모 분석과 전년대비 성장률(YoY) : 용도별
  • 시장 매력 지수 : 용도별
    • 의료용 영양/유아 영양
    • 스포츠 영양
    • 과민성장증후군
    • 만성 췌장염
    • 소화불량
    • 추가 보충제

제10장 세계의 소화 효소 시장 : 유통 채널별

  • 서론
  • 시장 규모 분석과 전년대비 성장률(YoY) : 유통 채널별
  • 시장 매력 지수 : 유통 채널별
    • 소매점
    • 온라인 스토어

제11장 세계의 소화 효소 시장 : 지역별

  • 서론
  • 시장 규모 분석과 전년대비 성장률(YoY) : 지역별
  • 시장 매력 지수 : 지역별
  • 북미
    • 서론
    • 지역내 시장 고유 동향
    • 시장 규모 분석과 전년대비 성장률(YoY) : 효소 종류별
    • 시장 규모 분석과 전년대비 성장률(YoY) : 원료별
    • 시장 규모 분석과 전년대비 성장률(YoY) : 용도별
    • 시장 규모 분석과 전년대비 성장률(YoY) : 유통 채널별
    • 시장 규모 분석과 전년대비 성장률(YoY) : 국가별
  • 유럽
  • 남미
  • 아시아태평양
  • 중동 및 아프리카

제12장 세계의 소화 효소 시장 : 경쟁 상황

  • 경쟁 시나리오
  • 시장 포지셔닝/점유율 분석
  • 기업 인수합병(M&A) 분석

제13장 세계의 소화 효소 시장 : 기업 개요

  • Zeus Biotech Limited
    • 기업 개요
    • 제품 포트폴리오/개요
    • 최근의 동향
    • 재무 분석 : 개요
  • Klaire Labs
  • Amway Corporation
  • AbbVie Inc.
  • Biotics Research Corporation
  • National Enzyme Company
  • Country Life LLC.
  • Garden Of Life Inc.
  • Rainbow Light Nutritional Systems Inc.
  • Food State Inc.
  • 기타 기업

제14장 세계의 소화 효소 시장 - 중요 인사이트

제15장 DataM Intelligence 소개

KSM 20.11.03

Market Overview

The global digestive enzymes market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Digestive enzymes are a group of enzymes that break down polymeric macromolecules into their smaller building blocks, in order to facilitate their absorption by the body. Digestive enzymes play a key role in regulating and maintaining the functions of the digestive system properly. These enzymes not only helps in digestion but due to excess or lack of these enzymes, one can face difficulties in digestions too.

Market Dynamics

The global digestive enzymes market growth is driven by the increasing prevalence of gastrointestinal disorders, awareness about the gastrointestinal health, increasing focus to the preventive health management are the factors to the global digestive enzymes market growth in the forecast period.

Increasing geriatric population and the rising prevalence of gastrointestinal disorders

The global population is aging rapidly, owing to reduced birth rates and increasing life expectancy. The demographic trend toward an aging population represents a growing need for the management of disorders, such as GI tract obstructions. According to the report "World Ageing Population, 2019", the older population of age 65 and above accounted for approximately 702.9 million all around the world, and it is expected to reach around 1,548.9 million.

The secretion of digestive enzymes usually decreases with age, which contributes to high levels of gastric discomfort, lower digestion rates, reduced food consumption, and/or a variety of other GI disorders. Therefore, with the increasing geriatric population, the market for digestive enzymes is expected to increase, over the forecast period.

Presence of a large number of small and big companies will drive the market

Presence of a large number of small and big companies makes the global market for digestive enzymes competitive in nature. Digestive enzyme supplements have to comply with various regulatory bodies including the U.S. Food and Drug Administration, Dietary Supplement Health and Education Act of 1994, and Natural Health Products Regulations for manufacturing and use. In order to grow in such a competitive environment, the established players are investing heavily in research and development to come up with better products. They are also embarking upon partnerships with retail chain companies to improve sales.

Risks associated with use is likely to hinder the market growth

However, the risks for most enzyme supplements are pretty minimal. Digestive enzymes may trigger a number of side effects, including stomach pain, nausea, diarrhea, and vomiting. In addition, some people may experience allergic reactions to digestive enzymes.

Bromelain, the enzyme from the pineapple, may have anti-platelet activity. If a person take blood thinners or have anti-platelet activity, taking it could possibly increase the risk of bleeding. Pregnant and lactating women are advised to consult their doctor before taking these products.

COVID-19 Impact Analysis

Although COVID-19 primarily a respiratory disease, growing evidence shows that it can affect the digestive system and present with gastrointestinal (GI) symptoms. In patients with COVID-19, the normal intestinal mucosa can be disrupted by the severe acute respiratory syndrome coronavirus virus, and this could result in GI symptoms and a compromise in nutrient absorption. Optimization of oral diet is still recommended. However, given the GI effects of COVID-19, a fraction of infected patients have poor appetite and would not be able to meet their nutrition goals with oral diet alone. For this at-risk group, which includes those who are critically ill, enteral nutrition is the preferred route to promote gut integrity and immune function. In carrying this out, nutrition support practices have been revised in such ways to mitigate viral transmission and adapt to the pandemic. To counter this situation the doctors are prescribing the digestive enzymes to the patients. Thus, the pandemic has incresed the sale and ultimately growth of the digestive enzymes market in the forecast period.

Segment Analysis

Amylase segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Amylase is essential for the digestion of carbohydrates. It breaks down starches into sugars. Amylase is secreted by both the salivary glands and the pancreas. The measurement of amylase levels in the blood is sometimes used as an aid in diagnosing various pancreas or other digestive tract diseases. High levels of amylase in the blood may indicate a blocked or injured duct of the pancreas, pancreatic cancer, or acute pancreatitis, a sudden inflammation of the pancreas.

Low levels may indicate chronic pancreatitis (ongoing inflammation of the pancreas) or liver disease. Amylase health benefits include the ability to fight diabetes. According to a 2013 study published in the Journal of Clinical & Diagnostic Research, type 2 diabetes patients were found to have high blood sugar levels that correlated with low serum amylase levels. The study suggests that amylase plays an important role in maintaining the health of the pancreas. Low amylase levels have been linked to an increased risk of diabetes as well as metabolic syndrome. Amylase health benefits include the ability to reverse diabetes symptoms by reducing high blood sugar levels.

Amylase has the ability to provide the body with a natural source of energy. It helps break down starch so the body can use it as fuel. Amylase plays an important role in breaking down high-starch foods like bread, grains, cereal, rice, pasta, beans, potatoes and corn. Without amylase, the body wouldn't be able to convert these carbohydrates into energy.

By processing starches in diet, amylase aids in the digestive process. It helps the body absorb nutrients form the food while breaking down carbohydrates. Amylase helps keep digestive problems at bay while ensuring that your body absorbs the nutrients from the food we eat

The animal origin are expected to dominate the digestive enzymes market during the forecast period

The major factors responsible for the growth of this segment include the efficiency of these animal-derived enzymes in various diseases or conditions, such as pancreatitis, exocrine pancreatic insufficiency, and pancreatic cancer. Hence, the rising prevalence of these diseases may influence market growth. Digestive enzymes from animal origin often come from the pancreatic or stomach enzymes in cows or pigs. Unlike plant-based enzymes, they are only functional at higher pH levels. Therefore, they are less efficient for aiding digestion in the stomach compared to plant-based digestive enzymes. However, specific animal-based enzymes such as pancreatin may be useful for aiding conditions such as pancreatitis, exocrine pancreatic insufficiency, and pancreatic cancer. Pancreatin contains the proteases, amylases, and lipases that a normally functioning pancreas would have; therefore, this enzyme would be useful for targeting an isolated problem in the pancreas.

According to the Cancer Research UK, new cases for pancreatic cancer accounted for almost 10, 257 in the United Kingdom, for 2015-2017. The animal-based enzyme is currently preferred as standard care of treatment for these diseases. The reason behind it may be similar pathophysiology of humans and animals. For instance, the pancreatic pathophysiology of hogs is very much alike to that of humans. However, ethical issues associated with animal origin products in some consumers are expected to hamper the segment's growth.

The microbial enzyme, on the other hand, is expected to witness the fastest growth rate over the forecast period. This growth rate of the microbial origin products can be attributed to factors, such as low production cost and high enzymatic activity. Microbial enzymes are capable of degrading toxic chemical compounds of industrial and domestic wastes (phenolic compounds, nitriles, amines etc.) either via degradation or conversion.

The microbial enzymes have gained recognition globally for their widespread uses in various sectors of industries, e.g., food, agriculture, chemicals, medicine, and energy. Enzyme mediated processes are rapidly gaining interest because of reduced process time, intake of low energy input, cost effective, nontoxic and eco-friendly characteristics. This factor is driving the growth of the segment in the forecast period.

Geographical Analysis

North America region holds the largest market share global digestive enzymes market

North America region is dominating the global digestive enzymes market accounted for the largest market share in 2020, owing to the large investment in healthcare and pressing schedules and unhealthy eating habits of people, primarily in the U.S. is said to be driving the market in the region. The increasing prevalence of chronic gastrointestinal diseases, rapidly aging population, growing demand for preventive medicine, and the presence of major market players are primary factors contributing to the large market size. According to the US Census Bureau, in 2018, the geriatric population in the United States was recorded with approximately 52 million. Furthermore, in 2018, around 14.8 million people were diagnosed with ulcers in the United States, according to the Centers for Disease Control and Prevention.

Competitive Landscape

The digestive enzymes market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Zeus Biotech Limited, Klaire Labs, Amway Corporation, AbbVie Inc., and Biotics Research Corporation, National Enzyme Company, Country Life LLC., Garden Of Life Inc., Rainbow Light Nutritional Systems Inc., Food State Inc among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the candidiasis therapeutics market globally.

Digestive Enzymes Market Key Companies to Watch

Klaire Labs

Overview: Klaire Labs is the flagship brand of SFI USA, which is based in Reno Nevada. The SFI group is a global premium natural healthcare company with headquarters in Sydney, Australia. Tribune. For nearly half a century, Klaire Labs has been developing premium, hypoallergenic supplements sold exclusively through healthcare professionals. To formulate and manufacture the purest, most potent nutraceuticals possible, thereby empowering clinicians with consistently reliable performance.

In 2017, three brands become one as sister brands ProThera Inc. and Complementary Prescriptions unify under Klaire Labs.

Product Portfolio: The Company's portfolio comprised of amino acids and proteins, accessory nutrients, hormones, and glandular, antioxidants and cell protectors, enzymes, lipids and essential fatty acids, topical products and others.

Why Purchase the Report?

  • Visualize the composition of the digestive enzyme market segmentation by enzyme type, origin, application, and distribution channel highlighting the key commercial assets and players.
  • Identify commercial opportunities in digestive enzyme market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of digestive enzyme market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global digestive enzyme market report would provide an access to an approx. 77 market data table, 69 figures and 300 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Oral Contraceptive Pills Market - By Enzyme Type

  • Carbohydrase
  • Protease
  • Lipase
  • Amylase
  • Maltase
  • Lactase
  • Other

Global Oral Contraceptive Pills Market - By Origin

  • Animal
  • Microbial
  • Plant

Global Oral Contraceptive Pills Market - By Application

  • Medical and Infant Nutrition
  • Sports Nutrition
  • Irritable Bowel syndrome
  • Chronic Pancreatitis
  • Indigestion
  • Additional Supplements

Global Oral Contraceptive Pills Market - By Distribution Channel

  • Retail Stores
  • Online Stores

Global Oral Contraceptive Pills Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Global Digestive Enzymes Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Digestive Enzymes Market - Market Definition and Overview

3. Global Digestive Enzymes Market - Executive Summary

  • 3.1. Market Snippet by Enzyme Type
  • 3.2. Market snippet by Origin
  • 3.3. Market snippet by Application
  • 3.4. Market Snippet by Distribution Channel
  • 3.5. Market Snippet by Region

4. Global Digestive Enzymes Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing awareness about GI health and focus on preventive Health Management
      • 4.1.1.2. Rising prevalence of gastrointestinal disorders
      • 4.1.1.3. Rising geriatric population
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent regulatory policies
      • 4.1.2.2. Risks associated to the use of digestive enzymes
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Digestive Enzymes Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Digestive Enzymes Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Digestive Enzymes Market - By Enzyme Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Enzyme Type Segment
    • 7.1.2. Market Attractiveness Index, By Enzyme Type Segment
  • 7.2. Carbohydrase*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Protease
  • 7.4. Lipase
  • 7.5. Amylase
  • 7.6. Maltase
  • 7.7. Lactase
  • 7.8. Other

8. Global Digestive Enzymes Market - By Origin

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Origin
    • 8.1.2. Market Attractiveness Index, By Origin
  • 8.2. Animal*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Microbial
  • 8.4. Plant

9. Global Digestive Enzymes Market - By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Medical and Infant Nutrition*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Sports Nutrition
  • 9.4. Irritable Bowel syndrome
  • 9.5. Chronic Pancreatitis
  • 9.6. Indigestion
  • 9.7. Additional Supplements

10. Global Digestive Enzymes Market - By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
    • 10.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 10.2. Retail Stores*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Online Stores

11. Global Digestive Enzymes Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Enzyme Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Origin
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Enzyme Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Origin
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Enzyme Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Origin
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Enzyme Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Origin
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Enzyme Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Origin
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Global Digestive Enzymes Market - Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of key companies to watch
  • 12.5. List of the company with disruptive technology
  • 12.6. List of start-up companies

13. Global Digestive Enzymes Market- Company Profiles

  • 13.1. Zeus Biotech Limited *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Klaire Labs
  • 13.3. Amway Corporation
  • 13.4. AbbVie Inc.
  • 13.5. Biotics Research Corporation
  • 13.6. National Enzyme Company
  • 13.7. Country Life LLC.
  • 13.8. Garden Of Life Inc.
  • 13.9. Rainbow Light Nutritional Systems Inc.
  • 13.10. Food State Inc.

LIST NOT EXHAUSTIVE

14. Global Digestive Enzymes Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us
Back to Top
전화 문의
F A Q